Myelodysplastic Syndrome (MDS) is a heterogeneous group of hematological disorders commonly characterized as a dysfunction of hematopoietic stem cells, leading to disordered production and inefficient blood formation in the bone marrow [1]. Typical manifestations of hematopoietic stem cell disorders include reduced peripheral blood cells, disorderly precursor cell differentiation, and increased or decreased bone marrow cells,…
Umbilical Cord Blood in the Treatment of Myelodysplastic Syndrome






